Merit Medical Systems to Announce Third Quarter Results on October 25, 2018
October 08 2018 - 9:25AM
Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer
and marketer of proprietary disposable devices used in
interventional, diagnostic and therapeutic procedures, particularly
in cardiology, radiology, oncology, critical care and endoscopy,
announced today that it will release its financial results for the
quarter ended September 30, 2018, after the close of the stock
market on Thursday, October 25, 2018.
Merit will hold its investor conference call (conference ID
6976085) on the same day (Thursday, October 25, 2018) at 5:00 p.m.
Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m.
Pacific). The telephone numbers to call are (domestic) (844)
578-9672; and (international) (508) 637-5656. A live webcast
will also be available for the conference call at merit.com.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is
engaged in the development, manufacture and distribution of
proprietary disposable medical devices used in interventional,
diagnostic and therapeutic procedures, particularly in cardiology,
radiology, oncology, critical care and endoscopy. Merit serves
client hospitals worldwide with a domestic and international sales
force and clinical support team totaling in excess of 300
individuals. Merit employs approximately 5,500 people
worldwide with facilities in South Jordan, Utah; Pearland, Texas;
Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts;
San Jose, California; Maastricht and Venlo, The Netherlands; Paris,
France; Galway, Ireland; Beijing, China; Tijuana, Mexico;
Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia;
Tokyo, Japan; and Singapore.
Contact: |
Anne-Marie Wright, Vice
President, Corporate Communications |
Phone: |
(801) 208-4167
e-mail: awright@merit.com Fax: (801) 253-1688 |
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Apr 2023 to Apr 2024